1. Home
  2. FRSH vs ARQT Comparison

FRSH vs ARQT Comparison

Compare FRSH & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Freshworks Inc.

FRSH

Freshworks Inc.

HOLD

Current Price

$12.85

Market Cap

3.7B

Sector

Technology

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$31.19

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRSH
ARQT
Founded
2010
2016
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.3B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
FRSH
ARQT
Price
$12.85
$31.19
Analyst Decision
Buy
Strong Buy
Analyst Count
16
7
Target Price
$19.44
$24.83
AVG Volume (30 Days)
4.2M
2.4M
Earning Date
11-05-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$810,640,000.00
$317,929,000.00
Revenue This Year
$18.20
$85.51
Revenue Next Year
$13.36
$30.74
P/E Ratio
N/A
N/A
Revenue Growth
18.18
129.21
52 Week Low
$10.51
$11.13
52 Week High
$19.77
$31.45

Technical Indicators

Market Signals
Indicator
FRSH
ARQT
Relative Strength Index (RSI) 68.09 69.89
Support Level $11.77 $28.95
Resistance Level $12.43 $31.27
Average True Range (ATR) 0.41 1.48
MACD 0.10 0.04
Stochastic Oscillator 89.80 93.97

Price Performance

Historical Comparison
FRSH
ARQT

About FRSH Freshworks Inc.

Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CS and ITSM categories and has also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and serve their customers and employees. The group derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and Other regions.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: